The pharmaceutical industry is continuously evolving, with growing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To meet https://crossbookmark.com/story20388590/leading-us-based-dulaglutide-api-manufacturing-services